To address this possibility, we performed ROC and PCA analyses for the two previously mentioned cancer types, hepatocellular carcinoma and gastric carcinoma, in which the Tks4 expression level had already been investigated as a biomarker by other researchers. This evidence concerns the gene SH3PXD2B and hepatocellular carcinoma.